ADPT vs BIIB: Which Stock is Better?
Side-by-side comparison of Adaptive Biotechnologies Corp and Biogen Inc in 2026
ADPT
Adaptive Biotechnologies Corp
$17.87
BIIB
Biogen Inc
$165.38
Key Metrics Comparison
| Metric | ADPT | BIIB | Winner |
|---|---|---|---|
| Market Cap | $2.67B | $24.26B | BIIB |
| P/E Ratio | N/A | 15.09 | BIIB |
| EPS (TTM) | $N/A | $10.96 | BIIB |
| Revenue Growth | 1.0% | 0.0% | ADPT |
| Gross Margin | 65.1% | 76.6% | BIIB |
Analyze ADPT
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ADPT or BIIB a better investment?
Comparing ADPT and BIIB: Adaptive Biotechnologies Corp has a market cap of $2.67B while Biogen Inc has $24.26B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ADPT and BIIB?
ADPT (Adaptive Biotechnologies Corp) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ADPT or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ADPT or BIIB?
ADPT has higher revenue growth at 1.0% vs 0.0% for BIIB.
Which company is more profitable: ADPT or BIIB?
Biogen Inc (BIIB) has higher gross margins at 76.6% compared to 65.1% for ADPT.
Which is the larger company: ADPT or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $24.26B compared to $2.67B for ADPT.
Should I buy ADPT or BIIB in 2026?
Both ADPT and BIIB have investment merit. ADPT trades at $17.87 while BIIB trades at $165.38. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ADPT and BIIB stock?
Key differences: Market Cap ($2.67B vs $24.26B), P/E Ratio (N/A vs 15.1x), Revenue Growth (1.0% vs 0.0%), Gross Margin (65.1% vs 76.6%).